A Phase 1 interventional study of Dietary Supplement: N-111 and Placebo in Cancer Breast and Cancer Prostate, sponsored by Optimal Health Research. Completed at 3 sites in 2 countries. Open to participants aged 25 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-10-03.
Sponsored by Optimal Health Research · Phase 1, Interventional, and Supportive care
The study will look at the end result of 2 types of diets effect on treatment outcome of cancer patients using N-111.
The study will be evaluated during a double blind, placebo-controlled evaluation of the effect diet has on the response of patients taking N-111 who are on a vegetarian diet vs a non-vegetarian diet or a placebo. This will involve assessing the patients progress or lack thereof over a 3-month period of time as outlined in Outcome Measures section below.
Optimal Health Research is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The group will use a vegetarian diet with the active compactor N-111.
Dietary Supplement: Dietary Supplement: N-111
The group will use a non-vegetarian diet with the active compactor N-111.
Dietary Supplement: Dietary Supplement: N-111
The group will use a vegetarian diet with a placebo.
Other: Placebo
The group will use a non-vegetarian diet with a placebo.
Other: Placebo
The group will use a vegetarian diet without the active compactor N-111 or the placebo.
he group will use a non-vegetarian diet without the active compactor N-111 or the placebo.
Dietary supplement N-111
Dietary placebo
Active Comparator: Vegetarian N-111 group
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Time frame: End of month 3.
Active Comparator: Non-vegetarian N-111 group.
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Time frame: End of month 3.
Placebo Comparator: Vegetarian placebo group
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Time frame: End of month 3.
Placebo Comparator: Non-vegetarian placebo control group
Change in blood levels (CA, CMP, CBC, CEA, Lipids, CRP) from base line to the end of month 3.
Time frame: End of month 3.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Optimal Health Research